Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 79

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 79
---
    $
    -

    $
    31,636

    Cost of services

    -

    1,575

    Research and development

    -

    48,820

    General and administrative

    1,108,182

    3,252,770

    Sales and marketing

    11,889

    153,973

    Total operating expenses
     
    $
    1,120,071

    $
    3,488,774

Our
total operating expenses for the six months ended June 30, 2025 decreased approximately 68% when compared to the same period in 2024.
Operating expenses changed as follows:

    ●
    Cost
        of products sold: cost of products sold for the six months ended June 30, 2025 decreased 100% when compared to the same period in
        2024. The decrease in cost of products sold aligns with the decrease in product sales in the first half of 2025, which is due to the Company
        scaling down its legacy operations and repositioning its business; 

    ●
    Cost
        of services: cost of services for the six months ended June 30, 2025 decreased 100% when compared to the same period in 2024. The
        decrease in cost of services aligns with the decrease in laboratory services in the first half of 2025, which is due to the Company scaling
        down its legacy operations and repositioning its business; and 

    ●
    Research
        and development, general and administrative, and sales and marketing: research and development, general and administrative, and sales
        and marketing expenses decreased approximately 100%, 66%, and 92%, respectively, for the six months ended June 30, 2025 compared
        to the same period in 2024. The decreases are primarily attributable to the Company scaling down its legacy operations and repositioning
        its business. 

27

Other
income (expense)

    Six Months Ended
        June 30,

    2025

    2024

    Interest and other income
     
    $
    226,688

    $
    150,668

    Interest expense

    (4,861
    )

    (1,079
    )
  
    Gain on impairment adjustment

    -

    2,079,575

    Change in fair value of EIB loan guar